市場調查報告書
商品編碼
1462692
2030 年天然膠原蛋白市場預測:按類型、原料、應用和地區分類的全球分析Native Collagen Market Forecasts to 2030 - Global Analysis By Type (Type I Collagen, Type II Collagen, Type III Collagen and Other Types), By Source (Bovine, Marine, Porcine, Poultry and Other Sources) Application and By Geography |
根據 Stratistics MRC 的資料,2023年全球天然膠原蛋白市場規模為 2.0507 億美元,預計到2030年將達到 3.124 億美元,預測期內年複合成長率為 6.2%。
天然膠原蛋白是指從牛和海洋動物組織等天然來源提取的膠原蛋白蛋白,處於未水解狀態。它保留了膠原蛋白有的分子結構和生理活性,使其與人體高度相容。天然膠原蛋白食品促進膠原蛋白合成和組織再生的潛力而廣泛用於護膚、創傷治療和營養補充。
根據美國疾病管制與預防中心(CDC)國家慢性病預防與健康促進中心(NCCDHPP)的資料,到2025年,美國將美國6,700 萬人患有關節炎。
人們對抗老化的興趣日益濃厚
隨著人口老化以及人們對護膚和健康意識的增強,對能夠解決皺紋、細紋和皮膚下垂等老化跡象的含膠原蛋白產品的需求不斷增加。由於其與人體的天然相容性以及改善皮膚彈性和水合作用的能力,天然膠原蛋白在化妝品和護膚品中越來越受到歡迎,推動了市場的成長。
生產成本高
從天然來源獲取高品質膠原蛋白所需的萃取和精製過程可能複雜且昂貴。此外,還需要嚴格的品管措施,進一步增加了生產成本。這些成本增加將影響膠原蛋白產品的最終定價,使其與合成替代品相比競爭力下降。此外,對有限原料來源的依賴也會導致成本波動,為市場上的製造商帶來挑戰。
增加膠原蛋白萃取方法的研發投入
透過利用技術和生物技術的進步,研究人員可以探索更有效且更具成本效益的方法從天然來源中提取膠原蛋白。此類創新可提高產量、提高純度並降低生產成本,進而提高膠原蛋白產品的整體競爭力。此外,研究和開發工作可能會發現膠原蛋白的新用途和功能,擴大潛在的市場範圍並促進該行業的進一步成長。
來自替代生物材料和合成替代品的競爭
合成材料具有品質穩定、製造成本低和減少對自然資源依賴等優點。此外,生物技術的進步促進了模仿天然膠原蛋白特性的仿生材料的開發。此類替代品通常以較低的價格提供類似的功能,這給天然膠原蛋白產品保持市場佔有率和價格競爭力帶來了挑戰,特別是在化妝品、藥品和醫療設備等行業。
COVID-19 大流行對天然膠原蛋白市場產生了各種影響。雖然醫療保健領域對膠原蛋白產品的需求不斷增加,特別是傷口護理和組織再生應用,但供應鏈中斷、消費者支出減少和優先事項的轉移對市場成長產生負面影響。然而,一旦經濟復甦並且對膠原蛋白產品的需求恢復,市場預計將會復甦。
食品和飲料領域預計將在預測期內成為最大的領域。
在天然膠原蛋白市場中,食品和飲料領域預計在預測期內將成為最大的市場。該成長是由於消費者對膠原蛋白健康益處的認知不斷提高,導致對含膠原蛋白產品的需求增加,包括機能飲料、零食和補充品。此外,製造商努力將膠原蛋白融入各種食品和飲料中,以提高營養價值並促進皮膚健康,也有助於該細分市場在市場格局中的主導地位。
預計 I 型膠原蛋白細分市場在預測期內年複合成長率最高。
預計 I 型膠原蛋白細分市場在預測期內將在天然膠原蛋白市場中表現出最高的成長率。這種成長歸因於 I 型膠原蛋白在製藥、化妝品和再生醫學等各行業的廣泛使用。 I型膠原蛋白在自然界中含量豐富,具有優異的生物相容性和生物活性,在創傷治療、組織工程和化妝品配方中的需求量很大,推動了市場的成長軌跡。
亞太地區預計將保持其在天然膠原蛋白市場的主導地位,因為其龐大的消費群和不斷增加的可支配收入推動化妝品、醫療保健和食品行業對膠原蛋白蛋白產品的需求。此外,人們對天然膠原蛋白益處的認知不斷增強,以及投資於研發的主要市場參與者的存在,進一步有助於鞏固亞太市場的領導地位。此外,積極的政府措施和分銷網路的擴張也支持該地區的市場成長。
歐洲的天然膠原蛋白市場可望快速成長。該地區擁有強大的醫療基礎設施和人口老化,對膠原蛋白醫療產品和補充品的需求不斷增加。此外,有利於天然和生物相容性材料的嚴格法規也有助於市場擴張。此外,消費者對護膚和個人保健產品中天然膠原蛋白益處的認知不斷提高,進一步刺激了市場成長,使歐洲成為投資和市場擴張的有希望的地區。
According to Stratistics MRC, the Global Native Collagen Market is accounted for $205.07 million in 2023 and is expected to reach $312.4 million by 2030 growing at a CAGR of 6.2% during the forecast period. Native collagen refers to collagen protein extracted from natural sources such as animal tissues, typically of bovine or marine origin, in its unaltered and unhydrolyzed form. It retains its original molecular structure and bioactive properties, making it highly compatible with the human body. Native collagen is widely used in skincare, wound healing, and dietary supplements for its potential to promote collagen synthesis and tissue regeneration.
According to the Centers for Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), 67 million of the total U.S. population is likely to suffer from arthritis by 2025.
Growing anti-aging concerns
With an aging population and increasing awareness about skincare and wellness, there's a heightened demand for collagen-based products to address signs of aging such as wrinkles, fine lines, and sagging skin. Native collagen, known for its natural compatibility with the human body and its ability to improve skin elasticity and hydration, is increasingly sought after in cosmetics and skincare formulations, driving market growth.
High production costs
The extraction and purification processes required to obtain high-quality collagen from natural sources can be intricate and expensive. Additionally, the need for stringent quality control measures further escalates production expenses. These elevated costs impact the final pricing of collagen-based products, making them less competitive compared to synthetic alternatives. Furthermore, the dependency on limited sources of raw materials also contributes to cost fluctuations, posing challenges for manufacturers in the market.
Increasing investment in research and development for novel collagen extraction methods
By leveraging advancements in technology and biotechnology, researchers can explore more efficient and cost-effective ways to extract collagen from natural sources. These innovations could lead to improved yields, higher purity levels, and reduced production costs, thereby enhancing the overall competitiveness of collagen-based products. Moreover, R&D efforts may uncover novel applications and functionalities of collagen, expanding its potential market reach and driving further growth in the industry.
Competition from alternative biomaterials and synthetic substitutes
Synthetic materials offer advantages such as consistent quality, lower production costs, and reduced reliance on natural resources. Additionally, advancements in biotechnology have led to the development of biomimetic materials that mimic the properties of native collagen. These substitutes often provide similar functionalities at a lower price point, posing a challenge for native collagen products to maintain market share and pricing competitiveness, especially in industries like cosmetics, pharmaceuticals, and medical devices.
The COVID-19 pandemic has had a mixed impact on the native collagen market. While there has been increased demand for collagen-based products in the healthcare sector, particularly for wound care and tissue regeneration applications, disruptions in the supply chain, reduced consumer spending, and shifting priorities have adversely affected market growth. However, the market is expected to rebound as economies recover and demand for collagen products resumes.
The food & beverages segment is expected to be the largest during the forecast period
The food and beverages segment is anticipated to emerge as the largest during the forecast period in the native collagen market. This growth is attributed to the rising demand for collagen-infused products, including functional beverages, snacks, and supplements, driven by consumers' growing awareness of collagen's health benefits. Additionally, manufacturers' efforts to incorporate collagen into various food and beverage formulations to enhance nutritional value and promote skin health contribute to the segment's dominance in the market landscape.
The type I collagen segment is expected to have the highest CAGR during the forecast period
The type I collagen segment is anticipated to exhibit the highest growth rate during the forecast period in the native collagen market. This growth is attributed to the widespread applications of type I collagen in various industries, including pharmaceuticals, cosmetics, and regenerative medicine. Type I collagen is abundant in nature and possesses excellent biocompatibility and bioactivity, making it highly sought after for wound healing, tissue engineering, and cosmetic formulations, thus driving its market growth trajectory.
Asia Pacific is poised to maintain its dominance in the native collagen market owing to the region's large consumer base and increasing disposable incomes, driving demand for collagen-based products in the cosmetics, healthcare, and food industries. Moreover, growing awareness of the benefits of native collagen and the presence of key market players investing in research and development further contribute to Asia Pacific's market leadership. Additionally, favorable government initiatives and expanding distribution networks bolster market growth in the region.
Europe is positioned for rapid growth in the native collagen market. The region boasts a robust healthcare infrastructure and a growing aging population, driving demand for collagen-based medical products and supplements. Additionally, stringent regulations favoring natural and biocompatible materials contribute to market expansion. Moreover, increasing consumer awareness about the benefits of native collagen in skincare and personal care products further stimulates market growth, making Europe a promising region for investment and market expansion.
Key players in the market
Some of the key players in Native Collagen Market include Bioiberica, Chinapeptide, Collagen Matrix, Inc., Collagen Solutions Plc, Ewald-Gelatine GmbH, GELITA AG, GELNEX, Hangzhou Nutrition Biotechnology Co., Ltd., Italgelatine S.p.A., Jellatech, Junca Gelatines, S.L., Narmada Gelatines Ltd., Nippi Collagen, Nitta Gelatin Inc., PB Gelatins (PB Leiner), Rousselot, Symatese, Tessenderlo Group, Trobas Gelatine B.V. and Vinh Hoan Corporation.
In March 2024, Varun Beverages, leading bottler of beverage major PepsiCo, is expanding its production capacities in the juices and value-added dairy products segments in 2024, according to the latest annual report of the company. Besides, Varun Beverages Ltd (VBL) is strengthening its distribution network and chilling infrastructure, which is essential to enhance presence in the existing and under-penetrated markets, its promoter & Non-Executive Chairman Ravi Jaipuria told shareholders.
In April 2023, India's leading milk and milk Product Company, Mother Dairy Fruit and Vegetable Pvt. Ltd has announced that it is releasing 15 new products for the summer of 2023. According to the company and its food developers, the new products were developed on the basis of consumer insights. These new products were aimed at tapping into indulgence and the consumer's evolving consumption pattern. The new products include ready-to-consume Custard, 2 Cold Coffees and over 10 Ice Cream variants. In addition, the company has enriched its Nutrifit Curd offering with Vitamins A & D.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.